0002029039 2026-09-01 2026-09-01 0002029039 1 2026-09-01 2026-09-01 iso4217:USD pure F-3 F-3 EX-FILING FEES 0002029039 Nasus Pharma Ltd N/A N/A F-3 Nasus Pharma Ltd false Equity Ordinary Shares, no par value per share true 50000000.00 0.0001381 6905.00 50000000.00 6905.00 0.00 0.00 6905.00 There are being registered under this registration statement such indeterminate number of securities as may be sold by the registrant from time to time, which collectively shall have an aggregate initial offering price not to exceed $50,000,000. The registrant is subject to the provisions of General Instruction I.B.5 of Form F-3, which provide that as long as the aggregate market value of the outstanding voting and non-voting common equity of the registrant held by non-affiliates is less than $75,000,000, then the aggregate market value of securities sold by or on behalf of the registrant on Form F-3, during the period of 12 calendar months immediately prior to, and including, such sale(s), is no more than one-third of the aggregate market value of the voting and non-voting common equity of the registrant held by non-affiliates as of a date within 60 days of such sale(s). In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, the Ordinary Shares being registered hereunder include such indeterminate number of Ordinary Shares as may be issuable with respect to the shares being registered hereunder as a result of share splits, share dividends or similar transactions. The proposed maximum offering price per unit has been omitted pursuant to Rule 457(o) under the Securities Act.